Vanderbilt Health One Hundred Oaks is a clinical research site located in Nashville, Tennessee, United States 37204.
Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.
Vanderbilt Health One Hundred Oaks has participated in 9 clinical trials with 6 currently active.
Therapeutic areas: Diabetes Mellitus, Type 2, Triple-Negative Breast Cancer, SARS-CoV-2 Infection.
Sponsors: Eli Lilly and Company, Merck Sharp & Dohme LLC, Shionogi.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt Health One Hundred Oaks has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt Health One Hundred Oaks has 9 clinical trials on record, with 6 currently active. Their work covers Diabetes Mellitus, Type 2, Triple-Negative Breast Cancer, SARS-CoV-2 Infection.
Vanderbilt Health One Hundred Oaks has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.